Singapore - Export of Vaccines for Human Use
Since 2014, Singapore Export of Vaccines for Human Use was up 1.9% year on year. With $136,660,795.29 in 2019, the country was number 15 among other countries in Export of Vaccines for Human Use. Singapore is overtaken by South Korea, which was ranked number 14 with $175,528,551.34 and is followed by Australia at $107,724,781.47. Belgium ranked the highest with $6,511,782,808.63 in 2019, +2.7% versus 2018. Ireland, United Kingdom and France respectively ranked number 2, 3 and 4 in this ranking. Nicaragua recorded the best 5 years average growth at +356.4% per year, while Dominican Republic witnessed the worst performance at -87.1% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 136,660,795.29 |
| 2018 | 139,350,064.00 |
| 2017 | 95,673,912.00 |
| 2016 | 84,684,552.00 |
| 2015 | 107,376,976.00 |
Download all data from 1989 to 2019
How does Singapore rank in Export of Vaccines for Human Use?
| # | 115 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Belgium
|
6,511,782,808.63 | 2019 | +2.7 % | -9.2 % | View data | |
| 2 |
#2
Ireland
|
5,792,918,864.55 | 2019 | -0.9 % | +16.3 % | View data | |
| 14 |
#14
South Korea
|
175,528,551.34 | 2019 | +5.8 % | -2.0 % | View data | |
| 15 |
#15
Singapore
|
136,660,795.29 | 2019 | -1.9 % | +1.9 % | View data | |
| 16 |
#16
Australia
|
107,724,781.47 | 2019 | +7.9 % | -1.2 % | View data | |